In Vivo Antiarrhythmic and Cardiac Electrophysiologic Effects of a Novel Diphenylphosphine Oxide IKur Blocker (2-Isopropyl-5-methylcyclohexyl) Diphenylphosphine Oxide-Reference-Cited by-同舟云学术

In Vivo Antiarrhythmic and Cardiac Electrophysiologic Effects of a Novel Diphenylphosphine Oxide IKur Blocker (2-Isopropyl-5-methylcyclohexyl) Diphenylphosphine Oxide

Published:2005-09-12 Issue:3 Volume:315 Page:1362-1367
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Stump Gary L.,Wallace Audrey A.,Regan Christopher P.,Lynch Joseph J.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference39 articles.

1. Stereochemistry of diphenylphosphide displacement at saturated carbon. Conformation and relative reactivity of menthyl- and neomenthyldiphenylphosphine homogeneous hydrogenation complexes

2. Differences between outward currents of human atrial and subepicardial ventricular myocytes.

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigative agents for atrial fibrillation: agonists and stimulants, progress and expectations;Expert Opinion on Investigational Drugs;2024-08-08

2. Dapagliflozin induces vasodilation in resistance-size mesenteric arteries by stimulating smooth muscle cell KV7 ion channels;Heliyon;2022-05

3. Peptide Inhibitors of Kv1.5: An Option for the Treatment of Atrial Fibrillation;Pharmaceuticals;2021-12-14

4. Empagliflozin Relaxes Resistance Mesenteric Arteries by Stimulating Multiple Smooth Muscle Cell Voltage-Gated K+ (KV) Channels;International Journal of Molecular Sciences;2021-10-07

5. New Strategies for the Treatment of Atrial Fibrillation;Pharmaceuticals;2021-09-15